I-View® Contrast Enhanced Mammography technology paired with Affirm Contrast Biopsy software provides customers with a complete contrast solution for use in the mammography suite. I-View 2.0 Contrast Enhanced Mammography (CEM) technology is an alternative to breast MRI – providing equivalent diagnostic performance. 1,2 The exam provides functional imaging information and highly detailed 2D images to increase diagnostic confidence with sensitivity and specificity to help guide the clinical pathway. Patients greatly prefer CEM over bMRI, for reasons such as faster procedure time, greater comfort, lower anxiety, and lower noise level. ³ The technology also offers a faster procedure as CEM is eight to 20 minutes of imaging time versus MRI’s 30 to 60 minutes. 4 Additionally, Hologic’s I-View CEM requires no pre-authorization and is 25% of the cost of an MRI. 5 The Affirm Contrast Biopsy solution allows clinicians to target and acquire tissue samples in lesions identified with CEM where a correlate may not be found on a FFDM, DBT or ultrasound image. The contrast agents used are the same as the ones commonly used in standard CT examinations. Contrast diagnostic exams and biopsy keep contrast exams in the mammography suite, using familiar mammography and biopsy procedures benefiting both providers and patients.
